United Therapeutics Corporation (UTHR) Hit a 52 Week High, Can the Run Continue?Zacks Investment Research • 07/15/24
United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary FibrosisBusiness Wire • 07/10/24
United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of DirectorsBusiness Wire • 06/27/24
United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceBusiness Wire • 06/05/24
Why Is United Therapeutics (UTHR) Up 4.8% Since Last Earnings Report?Zacks Investment Research • 05/31/24
United Therapeutics (UTHR) is an Incredible Growth Stock: 3 Reasons WhyZacks Investment Research • 05/06/24
United Therapeutics Corporation (UTHR) Hits Fresh High: Is There Still Room to Run?Zacks Investment Research • 05/06/24
Compared to Estimates, United Therapeutics (UTHR) Q1 Earnings: A Look at Key MetricsZacks Investment Research • 05/01/24
CORRECTING and REPLACING PHOTO United Therapeutics Announces World's First Successful Xenothymokidney TransplantBusiness Wire • 04/26/24
United Therapeutics Announces World's First Successful Xenothymokidney TransplantBusiness Wire • 04/24/24
United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024Business Wire • 04/24/24